Crinetics Pharmaceuticals Revenue and Competitors

Claim your profile

Location

$321M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Crinetics Pharmaceuticals's estimated annual revenue is currently $2.4M per year.(i)
  • Crinetics Pharmaceuticals received $63.5M in venture funding in March 2018.
  • Crinetics Pharmaceuticals's estimated revenue per employee is $16,745
  • Crinetics Pharmaceuticals's total funding is $321M.
  • Crinetics Pharmaceuticals's current valuation is $1.1B. (January 2022}

Employee Data

  • Crinetics Pharmaceuticals has 145 Employees.(i)
  • Crinetics Pharmaceuticals grew their employee count by 32% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27.4M177-14%$160MN/A
#2
$3.7M24N/AN/AN/A
#3
$18.1M117-4%$24.1MN/A
#4
$47.1M304-3%N/AN/A
#5
$48.1M310-7%$403MN/A
#6
$459.2M206854%$242.6MN/A
#7
$0.9M650%$6.1MN/A
#8
$14.9M96-17%$140MN/A
#9
$29M187-1%N/AN/A
#10
$3.7M24N/AN/AN/A

Neuropeptide Receptor Targeted Therapeutics for the Treatment of Endocrine Diseases and Cancers. We are driven by a passion for drug-hunting and tempered by a post-recession startup culture. Our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

$321M

Total Funding

145

Number of Employees

$2.4M

Revenue (est)

32%

Employee Growth %

$1.1B

Valuation

N/A

Accelerator

Crinetics Pharmaceuticals News

2022-04-19 - Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Forecasted to ... Defense World

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Forecasted to ... Defense World

2022-04-13 - Crinetics Pharmaceuticals Announces Pricing of Underwritten ... GlobeNewswire

Crinetics Pharmaceuticals Announces Pricing of Underwritten ... GlobeNewswire

2022-03-30 - Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year ... GlobeNewswire

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year ... GlobeNewswire

2021-10-28 - Radionetics Oncology Launches with $30M Investment

Photo Courtesy of Crinetics San Diego-based Crinetics Pharmaceuticals focuses on discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Radionetics Oncology, a pharmaceutical company developing radiotherapeutics, launched with $30 m ...

2021-10-25 - Crinetics Pharmaceuticals : Announces Closing of Public Offering of Common Stock

SAN DIEGO - October 25, 2021 - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that is has closed it ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.5M14524%$289.5M
#2
$42.1M145-7%$26M
#3
$32.7M1452%$105M
#4
$23.9M145N/AN/A
#5
$39.9M145-17%N/A

Crinetics Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2015-11-03$40.0MA5AM VenturesArticle
2018-03-15$63.5MBPerceptive AdvisorsArticle